Staff reporter at Mind and Margin, covering Mental Health.
Heidi Overton, a key health policymaker in the Trump administration, has been nominated to lead the Food and Drug Administration. Her appointment has raised concerns about her potential competing interests.
The new director of the Centers for Disease Control and Prevention, Erica Schwartz, has emphasized the importance of transparency and accountability in her first address to agency staff.
The American Cancer Society has canceled its upcoming Wine and Spirits Industry's Gala, citing a need to align events with its mission and prevention guidance.
The FDA has approved Regeneron's Pasatru for fibrodysplasia ossificans progressiva (FOP), a rare condition causing abnormal bone growth. The drug aims to slow disease progression, potentially preserving mobility and extending lifespan for patients who often rely on wheelchairs by age 25.
STAT, a leading healthcare publication, has launched a new initiative to address the crisis of trust in science, with a focus on exploring the origins of misinformation and promoting transparency and accountability in scientific institutions.
A recent patient death has led experts to scrutinize Huidagene's disclosures, raising concerns about the company's transparency and safety protocols.